264 related articles for article (PubMed ID: 34007173)
21. pH- and photothermal-driven multistage delivery nanoplatform for overcoming cancer drug resistance.
Huang W; Zhao H; Wan J; Zhou Y; Xu Q; Zhao Y; Yang X; Gan L
Theranostics; 2019; 9(13):3825-3839. PubMed ID: 31281516
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
23. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
[TBL] [Abstract][Full Text] [Related]
24. The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model.
Mirhadi E; Askarizadeh A; Farhoudi L; Mashreghi M; Behboodifar S; Alavizadeh SH; Arabi L; Jaafari MR
Chem Phys Lipids; 2024 Jul; 261():105396. PubMed ID: 38621603
[TBL] [Abstract][Full Text] [Related]
25. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
26. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
[No Abstract] [Full Text] [Related]
27. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
28. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
29. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
[No Abstract] [Full Text] [Related]
30. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
Mamasheva E; O'Donnell C; Bandekar A; Sofou S
Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
[TBL] [Abstract][Full Text] [Related]
31. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
[TBL] [Abstract][Full Text] [Related]
32. Multi-stimuli responsive hollow MnO
Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
[TBL] [Abstract][Full Text] [Related]
33. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
34. Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance.
Chen Y; Cheng Y; Zhao P; Zhang S; Li M; He C; Zhang X; Yang T; Yan R; Ye P; Ma X; Xiang G
Int J Pharm; 2018 May; 542(1-2):266-279. PubMed ID: 29551747
[TBL] [Abstract][Full Text] [Related]
35. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
36. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
37. pH/H
Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104
[TBL] [Abstract][Full Text] [Related]
38. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
39. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.
Shi M; Zhang J; Li X; Pan S; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
Int J Nanomedicine; 2018; 13():4209-4226. PubMed ID: 30140154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
